BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7902444)

  • 1. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene diagnosis of pancreatic adenocarcinoma].
    Wang ZY; Liu TH; Cui QC
    Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):270-3. PubMed ID: 7874757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions.
    Trümper LH; Bürger B; von Bonin F; Hintze A; von Blohn G; Pfreundschuh M; Daus H
    Br J Cancer; 1994 Aug; 70(2):278-84. PubMed ID: 8054276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Malats N; Porta M; Fernandez E; Real FX
    J Natl Cancer Inst; 1994 Sep; 86(17):1353-4; author reply 1355. PubMed ID: 7914938
    [No Abstract]   [Full Text] [Related]  

  • 6. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q; Wang Z; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
    Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M
    Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
    Tada M; Omata M; Ohto M
    Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
    Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
    Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas.
    Shibata D; Almoguera C; Forrester K; Dunitz J; Martin SE; Cosgrove MM; Perucho M; Arnheim N
    Cancer Res; 1990 Feb; 50(4):1279-83. PubMed ID: 2404591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis.
    Inoue S; Nakao A; Kasai Y; Harada A; Nonami T; Takagi H
    Jpn J Cancer Res; 1995 Jul; 86(7):626-30. PubMed ID: 7559078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational activation of the c-K-ras gene in human pancreatic carcinoma.
    Shibata D; Capella G; Perucho M
    Baillieres Clin Gastroenterol; 1990 Mar; 4(1):151-69. PubMed ID: 1976394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
    Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncogene expression and point mutation in human pancreatic adenocarcinomas].
    Li DC; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):152-5. PubMed ID: 1477938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.
    van Es JM; Polak MM; van den Berg FM; Ramsoekh TB; Craanen ME; Hruban RH; Offerhaus GJ
    J Clin Pathol; 1995 Mar; 48(3):218-22. PubMed ID: 7730480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas.
    Grünewald K; Lyons J; Fröhlich A; Feichtinger H; Weger RA; Schwab G; Janssen JW; Bartram CR
    Int J Cancer; 1989 Jun; 43(6):1037-41. PubMed ID: 2659539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of pancreatic lesions using fine needle aspiration cytology: detection of K-ras point mutations using solid phase minisequencing.
    Ihalainen J; Taavitsainen M; Salmivaara T; Palotie A
    J Clin Pathol; 1994 Dec; 47(12):1082-4. PubMed ID: 7876379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of Ki-ras oncogene mutations in normal mucosa, adenoma and adenocarcinoma of the colon].
    Wang ZY
    Zhonghua Bing Li Xue Za Zhi; 1993 Dec; 22(6):333-6. PubMed ID: 7913419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.
    Motojima K; Urano T; Nagata Y; Shiku H; Tsunoda T; Kanematsu T
    Am J Gastroenterol; 1991 Dec; 86(12):1784-8. PubMed ID: 1962623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent activation of the Ki-ras oncogene at codon 12 in N-methyl-N-nitrosourea-induced rat prostate adenocarcinomas and neurogenic sarcomas.
    Sukumar S; Armstrong B; Bruyntjes JP; Leav I; Bosland MC
    Mol Carcinog; 1991; 4(5):362-8. PubMed ID: 1680340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.